ConnSante BioTech & Innovation, INC.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
ConnSante offers services such as the anti-cancer capability test, immune and tissue-repair system diagnostics, cancer prognosis and risk-assessment services, and tailored health-management and follow-up programs — particularly aimed at high-risk groups o
The content above was translated by Ai
Founded Year
2025
Unified Business No.
60756906
Status
Active
Number of Employees
0
Total Paid-in
Capital
13,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
ConnSante Biotech is a molecular and cellular diagnostics company that, based on 25 years of research, developed a proprietary “anti-cancer capability test” designed to assess the health status of stem cells and immune cells — helping individuals evaluate cancer risk and manage long-term health.
The content above was translated by Ai
